Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07732686) titled 'Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry' on July 23.
Study Type: Observational
Primary Sponsor: University of Oklahoma
Condition:
Pancreas Cancer
Hepatocellular Carcinoma
Lung Cancer
Ovarian Cancer
Breast Cancer
Head and Neck Cancer
Colon Cancer
Bladder Cancer
Other Cancer
Intervention:
Device: Proton Transfer Reaction Mass Spectrometry Analysis
Recruitment Status: Not recruiting
Date of First Enrollment: October 2026
Target Sample Size: 2000
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07732686
Disclaimer: Curated by HT Synd...